Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Madina A. Gappoeva"'
Autor:
Sofia V. Timofeeva, Oleg I. Kit, Svetlana Yu Filippova, Anastasia O. Sitkovskaya, Irina V. Mezhevova, Nadezhda V. Gnennaya, Tatiana V. Shamova, Inna A. Novikova, Elena Yu Zlatnik, Yaroslav S. Enin, Oleg N. Burov, Dmitry A. Kharagezov, Oleg N. Stateshny, Anton G. Milakin, Igor A. Leyman, Ellada A. Mirzoyan, Madina A. Gappoeva, Victoria N. Vitkovskaya, Kristian D. Iozefi, Yuriy N. Lazutin
Publikováno v:
Journal of Clinical Oncology. 40:e15079-e15079
e15079 Background: Initially, berberine was used as an antimicrobial agent in traditional medicine, but its anticancer properties were later discovered. In addition to its cytotoxic effect, berberine also has the ability to inhibit cell motility, whi
Autor:
Denis S. Kutilin, Mikhail S. Zinkovich, Marina A. Gusareva, Aleksey N. Shevchenko, Aleksandr V. Faenson, Anna A. Solntseva, Natalya B. Fatkina, Ekaterina O. Vasilieva, Elena V. Filatova, Natalia G Kosheleva, Ekaterina A. Tolmacheva, Ksenia V. Martynova, Madina A. Gappoeva, Irina A. Udalenkova, Irina A. Khomutenko, Lyudmila Ya Rozenko, Inna V. Pavlyatenko, Astanda K. Gvaramiya, Oleg I. Kit
Publikováno v:
Journal of Clinical Oncology. 40:e17008-e17008
e17008 Background: Radiotherapy (RT) is one of the main treatments for prostate cancer (PC). The effectiveness of RT depends on the initial radioresistance of tumor cells provided by their certain molecular features - the transcriptional activity of
Autor:
Irina V. Mezhevova, Oleg I. Kit, Svetlana Yu Filippova, Anastasia O. Sitkovskaya, Nadezhda V. Gnennaya, Tatiana V. Shamova, Sofia V. Timofeeva, Inna A. Novikova, Elena Yu Zlatnik, Yaroslav S. Enin, Oleg N. Burov, Dmitry A. Kharagezov, Oleg N. Stateshny, Anton G. Milakin, Igor A. Leyman, Ellada A. Mirzoyan, Madina A. Gappoeva, Yuriy N. Lazutin, Victoria N. Vitkovskaya, Kristian D. Iozefi
Publikováno v:
Journal of Clinical Oncology. 40:e15097-e15097
e15097 Background: The energy metabolism of tumor cells and infiltrating stromal cells is a promising target in anticancer therapy. One of the mechanisms of antitumor activity of berberine is its ability to suppress oxidative phosphorylation in cance
Autor:
Natalya N. Timoshkina, Natalia A. Petrusenko, Al-Nsour Rashed, Astanda K. Gvaramiya, Madina A. Gappoeva, Dmitriy A. Savchenko, Oleg I. Kit, Denis S. Kutilin
Publikováno v:
Journal of Clinical Oncology. 40:e20514-e20514
e20514 Background: Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancers and remains the most commonly diagnosed human neoplasm with a poor prognosis. Significantly improving the clinical course of NSCLC, EGFR tyrosine kinase inhibi
Autor:
Natalya N. Timoshkina, Natalia A. Petrusenko, Dmitry Yu. Gvaldin, Madina A. Gappoeva, Sergey E. Kavitskiy, Maria A. Cherkes, Ekaterina V. Verenikina, Denis S. Kutilin
Publikováno v:
Journal of Clinical Oncology. 40:e17548-e17548
e17548 Background: About 10-15% of malignant ovarian tumors (OC) are associated with hereditary diseases, and about 65-85% of hereditary OC have a mutation in BRCA1/2 genes. The aim of the study was to analyze BRCA1/2 genes hereditary mutation spectr
Autor:
Denis S. Kutilin, Natalia G Kosheleva, Marina A. Gusareva, Mikhail S. Zinkovich, Anna A. Solntseva, Natalya B. Fatkina, Ekaterina O. Vasilieva, Ekaterina A. Tolmacheva, Ksenia V. Martynova, Madina A. Gappoeva, Irina A. Udalenkova, Olga V. Shlyakhova, Inna V. Pavlyatenko, Petr N. Gabrichidze, Astanda K. Gvaramiya, Lyudmila Ya Rozenko, Vladislav M. Legostaev, Oleg I. Kit
Publikováno v:
Journal of Clinical Oncology. 40:e15536-e15536
e15536 Background: Radiotherapy (RT) is a key component of rectal cancer (RC) treatment, however, cases of non-response to preoperative RT in patients are very common, which is associated with radioresistance of tumor cells, mediated by their molecul
Autor:
Elena P. Ulianova, Oleg N. Stateshny, Aleksandr B. Sagakyants, Dmitry A. Kharagezov, Igor A. Leyman, Anton G. Milakin, Madina A. Gappoeva, Kristian D. Iozefi, Maksim N. Chernyak, Oksana G. Shulgina, Yuriy N. Lazutin, Elena A. Dzhenkova, Inna A. Novikova, Natalia N. Popova, Lyudmila Ya Rozenko
Publikováno v:
Journal of Clinical Oncology. 40:e20513-e20513
e20513 Background: Currently, an active search is underway for additional markers that predict the risk of tumor progression based on the epithelial-mesenchymal transition (EMT). Desmocollin 3 (DSC 3), a member of the Cadherin superfamily and a cell